You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

April 6, 2020

New Regulations on Animal Feed and Aquafeed in Vietnam

Subscribe to Updates

On March 9, 2020, Vietnam’s Ministry of Agricultural and Rural Development (MARD) issued Circular No. 04/2020/TT-BNNPTNT (“Circular 4”) on National Technical Regulations on animal feed and raw materials for production of aquafeed. Circular 4 will take effect on July 1, 2020, and will have an impact on entities engaging in animal feed and aquafeed activities in Vietnam. Some of the major changes are set out below.

Safety Parameters

Circular 4 promulgates National Technical Regulation No. QCVN 01-190:2020/BNNPTNT which sets the maximum levels of undesirable substances for (i) traditional animal feed and raw materials for production of aquafeed as specified in Annex I; (ii) animal feed supplements as specified in Annex II; and (iii) compound animal feed and concentrated animal feed as specified in Annex III.

Conformity Declaration

Animal feed and raw materials for production of aquafeed must meet the safety requirements mentioned above. Before such products are circulated in the Vietnamese market, the manufacturers, importers, or distributors must proceed with the conformity declaration procedure to announce that their commercial animal feeds and raw materials for production of aquafeed conform to the above safety requirements.

Manufacturers, importers, or distributors must base their declaration of conformity on one of the following types of evidence: (1) results of their self-assessment of conformity; (2) certified results of the assessment of conformity by a certified organization registered or recognized by the MARD; or (3) certified results of the assessment of conformity by a certified organization designated by provisions of law. For animal feed supplements, it is required for manufacturers, importers, or distributors to base their declaration on the results of an assessment of conformity carried out by a certified organization designated by provisions of law.

Method of Conformity Assessment

In order to obtain results of the assessment of conformity, it is required to apply Mode 5 or Mode 7 prescribed in Circular No. 28/2012/TT-BKHCN of the Ministry of Science and Technology, as amended by Circular No. 02/2017/ TT-BKHCN.

Transitional Provisions

For imported animal feed and raw materials for production of aquafeed that have completed customs clearance before July 1, 2020, it is not required to conduct procedures for conformity declaration. For domestically manufactured animal feed and raw materials for production of aquafeed that have had their product information sent to, published by, or requested to be published by the MARD before July 1, 2020, the products can be circulated as normal until June 30, 2021. However, to continue manufacturing and circulating the products after that date, the manufacturers or distributors must complete the procedures for conformity declaration before July 1, 2021.

For more information on the regulations, please contact us at [email protected].

Related Professionals

Industries

Life Sciences

Practices

Regulatory Affairs

Location

RELATED INSIGHTS​ 

July 4, 2023
Practitioners from Tilleke & Gibbins’ Vietnam offices contributed content for the latest edition of the Practical Law Life Sciences Global Guide. The guide provides a comparative overview, in Q&A format, of laws and regulations on pharmaceuticals, medical devices, and other life sciences products in dozens of jurisdictions around the world. The Life Sciences Global Guide is divided into two sections: Regulation (see more details here) and Commercialization, which covers the following topics: Overview of the life sciences sector Pricing, government funding, and reimbursement: National health care system, price regulation and reimbursement Distribution and sale Cross-border trade and parallel imports Advertising to the public and engagement with patient organizations Advertising to healthcare professionals and organizations: Gifts and incentives and transparency and disclosure Patents: Conditions for patentability, registration, length of protection, infringement, international treaties Trademarks: Requirements, registration Competition law issues: Authorities and legislation, commercial contracts and competition law, licensing approvals and formalities Product liability: Regulators, medicinal product liability law, liable partners, defenses, product liability claims, remedies Practical Law, produced by Thomson Reuters, is the world’s leading legal know-how resource for business lawyers, publishing a huge range of guides covering hundreds of jurisdictions and practice areas. The full “Life Sciences Commercialization in Vietnam” section can be found on the Practical Law website.
Read More
July 4, 2023
Practitioners from Tilleke & Gibbins’ Vietnam offices contributed content for the latest edition of the Practical Law Life Sciences Global Guide. The guide provides a comparative overview, in Q&A format, of laws and regulations on pharmaceuticals, medical devices, and other life sciences products in dozens of jurisdictions around the world. The Life Sciences Global Guide is divided into two sections: Commercialization (see more details here) and Regulation, which covers the following topics: Pharmaceuticals: Laws and regulatory authorities Clinical trials: Legal, regulatory, and procedural requirements Manufacturing and distribution Marketing: Authorization for marketing medicinal products, monitoring compliance and penalties, pharmacovigilance and other commitments, foreign marketing authorizations Data privacy Packaging, labeling, and tracking Biological medicines Medical devices: Legislation and regulatory authorities, definition and classification Healthcare IT Combination products and borderlines Natural health products Recent developments and reform proposals Practical Law, produced by Thomson Reuters, is the world’s leading legal know-how resource for business lawyers, publishing a huge range of guides covering hundreds of jurisdictions and practice areas. The full “Life Sciences Regulation in Vietnam” section can be found on the Practical Law website.
Read More
June 1, 2023
Life sciences specialists from Tilleke & Gibbins have supplied the Thailand and Vietnam contributions to the International Bar Association (IBA) Healthcare and Life Sciences Law Committee’s global telemedicine survey. The survey, spanning 54 jurisdictions worldwide, functions as a comparative legal guide on the provision of telemedicine and related products and services. It offers practitioners and industry users access to relevant rules and regulations, addressing key aspects such as regulation, data privacy, liability, and recent developments in telemedicine. Telemedicine has emerged as a transformative force in healthcare, revolutionizing the way medical services are accessed and delivered. As in many other jurisdictions, telemedicine has gained prevalence in Thailand and Vietnam, as it enables patients to remotely consult with healthcare professionals, access diagnostic services, and receive timely medical advice while minimizing physical contact. As the global healthcare landscape continues to evolve, understanding the legal and regulatory aspects of telemedicine becomes paramount, making initiatives like the IBA’s telemedicine survey vital for practitioners and industry stakeholders. The IBA is a globally recognized organization that brings together legal professionals and bar associations from around the world, and its Healthcare and Life Sciences Law Committee plays a crucial role in addressing legal issues and developments in the healthcare industry. The complete surveys for Thailand and Vietnam­—and the 52 other participating jurisdictions—are available on the IBA website.
Read More
May 23, 2023
Life sciences specialists at Tilleke & Gibbins’ office in Bangkok have contributed a new “Life Sciences Commercialization in Thailand” chapter to the Life Sciences Global Guide from Practical Law. The Q&A-style guide provides strategic information for companies active in the life sciences sector in Thailand. The chapter covers a number of key areas: Overview of the life sciences sector Pricing, government funding, and reimbursement: National health care system, price regulation and reimbursement Distribution and sale Cross-border trade and parallel imports Advertising and engagement with patient organizations Patents: Conditions for patentability, registration, length of protection, infringement, international treaties Trademarks: Requirements, registration Competition law issues: Authorities and legislation, commercial contracts and competition law, licensing approvals and formalities Product liability: Regulators, medicinal product liability law, liable partners, defenses, product liability claims, remedies Practical Law, produced by Thomson Reuters, is the world’s leading legal know-how resource for business lawyers, publishing a huge range of guides covering hundreds of jurisdictions and practice areas. The full “Life Sciences Commercialization in Thailand” section can be found on the Practical Law website.
Read More